nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2C8—Spironolactone—dilated cardiomyopathy	0.236	0.409	CbGbCtD
Cyclophosphamide—ABCB1—Lisinopril—dilated cardiomyopathy	0.182	0.314	CbGbCtD
Cyclophosphamide—ABCB1—Spironolactone—dilated cardiomyopathy	0.16	0.277	CbGbCtD
Cyclophosphamide—Bladder spasm—Furosemide—dilated cardiomyopathy	0.0253	0.06	CcSEcCtD
Cyclophosphamide—Hepatic encephalopathy—Furosemide—dilated cardiomyopathy	0.0219	0.0519	CcSEcCtD
Cyclophosphamide—Dry cough—Lisinopril—dilated cardiomyopathy	0.0154	0.0365	CcSEcCtD
Cyclophosphamide—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0105	0.025	CcSEcCtD
Cyclophosphamide—Diuresis—Furosemide—dilated cardiomyopathy	0.0102	0.0243	CcSEcCtD
Cyclophosphamide—Pancreatitis acute—Furosemide—dilated cardiomyopathy	0.00688	0.0163	CcSEcCtD
Cyclophosphamide—Amenorrhoea—Spironolactone—dilated cardiomyopathy	0.00664	0.0157	CcSEcCtD
Cyclophosphamide—Ulcer—Spironolactone—dilated cardiomyopathy	0.00617	0.0146	CcSEcCtD
Cyclophosphamide—Vasculitis—Spironolactone—dilated cardiomyopathy	0.00598	0.0142	CcSEcCtD
Cyclophosphamide—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00573	0.0136	CcSEcCtD
Cyclophosphamide—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.00551	0.0131	CcSEcCtD
Cyclophosphamide—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00459	0.0109	CcSEcCtD
Cyclophosphamide—Thrombosis—Furosemide—dilated cardiomyopathy	0.00449	0.0106	CcSEcCtD
Cyclophosphamide—Blister—Furosemide—dilated cardiomyopathy	0.00441	0.0104	CcSEcCtD
Cyclophosphamide—Cholestasis—Furosemide—dilated cardiomyopathy	0.00418	0.00991	CcSEcCtD
Cyclophosphamide—Inappropriate antidiuretic hormone secretion—Lisinopril—dilated cardiomyopathy	0.0041	0.00971	CcSEcCtD
Cyclophosphamide—Injection site pain—Furosemide—dilated cardiomyopathy	0.00389	0.00922	CcSEcCtD
Cyclophosphamide—Fluid overload—Lisinopril—dilated cardiomyopathy	0.00383	0.00908	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00382	0.00904	CcSEcCtD
Cyclophosphamide—Drug interaction—Furosemide—dilated cardiomyopathy	0.00342	0.00811	CcSEcCtD
Cyclophosphamide—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00342	0.00811	CcSEcCtD
Cyclophosphamide—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00334	0.0079	CcSEcCtD
Cyclophosphamide—Vasculitis—Furosemide—dilated cardiomyopathy	0.00325	0.00771	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00324	0.00767	CcSEcCtD
Cyclophosphamide—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00323	0.00766	CcSEcCtD
Cyclophosphamide—Renal failure—Spironolactone—dilated cardiomyopathy	0.00321	0.00761	CcSEcCtD
Cyclophosphamide—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00316	0.0075	CcSEcCtD
Cyclophosphamide—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00311	0.00737	CcSEcCtD
Cyclophosphamide—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00311	0.00737	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00305	0.00722	CcSEcCtD
Cyclophosphamide—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00294	0.00697	CcSEcCtD
Cyclophosphamide—Bladder pain—Furosemide—dilated cardiomyopathy	0.00287	0.0068	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00277	0.00657	CcSEcCtD
Cyclophosphamide—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00265	0.00628	CcSEcCtD
Cyclophosphamide—Viral infection—Lisinopril—dilated cardiomyopathy	0.00264	0.00625	CcSEcCtD
Cyclophosphamide—Polyuria—Furosemide—dilated cardiomyopathy	0.00262	0.00622	CcSEcCtD
Cyclophosphamide—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00262	0.00621	CcSEcCtD
Cyclophosphamide—Swelling—Furosemide—dilated cardiomyopathy	0.00261	0.00619	CcSEcCtD
Cyclophosphamide—Alopecia—Spironolactone—dilated cardiomyopathy	0.00259	0.00614	CcSEcCtD
Cyclophosphamide—Deafness—Furosemide—dilated cardiomyopathy	0.00258	0.00611	CcSEcCtD
Cyclophosphamide—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00257	0.00609	CcSEcCtD
Cyclophosphamide—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00255	0.00605	CcSEcCtD
Cyclophosphamide—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00245	0.00581	CcSEcCtD
Cyclophosphamide—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00244	0.00578	CcSEcCtD
Cyclophosphamide—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00241	0.00571	CcSEcCtD
Cyclophosphamide—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00238	0.00565	CcSEcCtD
Cyclophosphamide—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00238	0.00565	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00237	0.00561	CcSEcCtD
Cyclophosphamide—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00234	0.00555	CcSEcCtD
Cyclophosphamide—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00233	0.00551	CcSEcCtD
Cyclophosphamide—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00231	0.00548	CcSEcCtD
Cyclophosphamide—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00231	0.00548	CcSEcCtD
Cyclophosphamide—Malaise—Spironolactone—dilated cardiomyopathy	0.0023	0.00545	CcSEcCtD
Cyclophosphamide—Cystitis—Lisinopril—dilated cardiomyopathy	0.0023	0.00545	CcSEcCtD
Cyclophosphamide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00228	0.00541	CcSEcCtD
Cyclophosphamide—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00226	0.00536	CcSEcCtD
Cyclophosphamide—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00215	0.0051	CcSEcCtD
Cyclophosphamide—Discomfort—Spironolactone—dilated cardiomyopathy	0.00215	0.00509	CcSEcCtD
Cyclophosphamide—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00212	0.00503	CcSEcCtD
Cyclophosphamide—Confusional state—Spironolactone—dilated cardiomyopathy	0.0021	0.00498	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00208	0.00493	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00208	0.00492	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00204	0.00483	CcSEcCtD
Cyclophosphamide—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00199	0.00471	CcSEcCtD
Cyclophosphamide—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00198	0.00469	CcSEcCtD
Cyclophosphamide—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00195	0.00462	CcSEcCtD
Cyclophosphamide—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00192	0.00456	CcSEcCtD
Cyclophosphamide—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00192	0.00454	CcSEcCtD
Cyclophosphamide—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.0019	0.0045	CcSEcCtD
Cyclophosphamide—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00187	0.00444	CcSEcCtD
Cyclophosphamide—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00182	0.00432	CcSEcCtD
Cyclophosphamide—Renal impairment—Lisinopril—dilated cardiomyopathy	0.00182	0.00431	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.0018	0.00426	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00176	0.00417	CcSEcCtD
Cyclophosphamide—Renal failure—Furosemide—dilated cardiomyopathy	0.00175	0.00414	CcSEcCtD
Cyclophosphamide—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00174	0.00411	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00172	0.00407	CcSEcCtD
Cyclophosphamide—Sweating—Furosemide—dilated cardiomyopathy	0.0017	0.00404	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00166	0.00393	CcSEcCtD
Cyclophosphamide—Urticaria—Spironolactone—dilated cardiomyopathy	0.00165	0.00392	CcSEcCtD
Cyclophosphamide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00165	0.0039	CcSEcCtD
Cyclophosphamide—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00164	0.0039	CcSEcCtD
Cyclophosphamide—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00156	0.00369	CcSEcCtD
Cyclophosphamide—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00155	0.00366	CcSEcCtD
Cyclophosphamide—Visual impairment—Furosemide—dilated cardiomyopathy	0.00154	0.00364	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00153	0.00364	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00151	0.00357	CcSEcCtD
Cyclophosphamide—Tinnitus—Furosemide—dilated cardiomyopathy	0.00149	0.00352	CcSEcCtD
Cyclophosphamide—Pruritus—Spironolactone—dilated cardiomyopathy	0.00147	0.00349	CcSEcCtD
Cyclophosphamide—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00147	0.00348	CcSEcCtD
Cyclophosphamide—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00146	0.00345	CcSEcCtD
Cyclophosphamide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00142	0.00338	CcSEcCtD
Cyclophosphamide—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00142	0.00338	CcSEcCtD
Cyclophosphamide—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00142	0.00336	CcSEcCtD
Cyclophosphamide—Erythema—Furosemide—dilated cardiomyopathy	0.00139	0.00329	CcSEcCtD
Cyclophosphamide—Dizziness—Spironolactone—dilated cardiomyopathy	0.00138	0.00326	CcSEcCtD
Cyclophosphamide—Weight increased—Lisinopril—dilated cardiomyopathy	0.00136	0.00322	CcSEcCtD
Cyclophosphamide—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00136	0.00322	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00135	0.0032	CcSEcCtD
Cyclophosphamide—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00134	0.00318	CcSEcCtD
Cyclophosphamide—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00133	0.00316	CcSEcCtD
Cyclophosphamide—Vomiting—Spironolactone—dilated cardiomyopathy	0.00132	0.00314	CcSEcCtD
Cyclophosphamide—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00132	0.00313	CcSEcCtD
Cyclophosphamide—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00131	0.00311	CcSEcCtD
Cyclophosphamide—Rash—Spironolactone—dilated cardiomyopathy	0.00131	0.00311	CcSEcCtD
Cyclophosphamide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00131	0.00311	CcSEcCtD
Cyclophosphamide—Renal failure—Lisinopril—dilated cardiomyopathy	0.00131	0.0031	CcSEcCtD
Cyclophosphamide—Vision blurred—Furosemide—dilated cardiomyopathy	0.00131	0.0031	CcSEcCtD
Cyclophosphamide—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00131	0.0031	CcSEcCtD
Cyclophosphamide—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00131	0.0031	CcSEcCtD
Cyclophosphamide—Headache—Spironolactone—dilated cardiomyopathy	0.0013	0.00309	CcSEcCtD
Cyclophosphamide—Jaundice—Lisinopril—dilated cardiomyopathy	0.0013	0.00308	CcSEcCtD
Cyclophosphamide—Anaemia—Furosemide—dilated cardiomyopathy	0.00128	0.00304	CcSEcCtD
Cyclophosphamide—Sweating—Lisinopril—dilated cardiomyopathy	0.00128	0.00303	CcSEcCtD
Cyclophosphamide—Agitation—Furosemide—dilated cardiomyopathy	0.00128	0.00302	CcSEcCtD
Cyclophosphamide—Haematuria—Lisinopril—dilated cardiomyopathy	0.00127	0.00301	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00124	0.00295	CcSEcCtD
Cyclophosphamide—Leukopenia—Furosemide—dilated cardiomyopathy	0.00124	0.00294	CcSEcCtD
Cyclophosphamide—Nausea—Spironolactone—dilated cardiomyopathy	0.00124	0.00293	CcSEcCtD
Cyclophosphamide—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00122	0.00289	CcSEcCtD
Cyclophosphamide—Rhinitis—Lisinopril—dilated cardiomyopathy	0.0012	0.00284	CcSEcCtD
Cyclophosphamide—Hepatitis—Lisinopril—dilated cardiomyopathy	0.0012	0.00284	CcSEcCtD
Cyclophosphamide—Confusional state—Furosemide—dilated cardiomyopathy	0.00114	0.00271	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00113	0.00268	CcSEcCtD
Cyclophosphamide—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00113	0.00268	CcSEcCtD
Cyclophosphamide—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00112	0.00264	CcSEcCtD
Cyclophosphamide—Shock—Furosemide—dilated cardiomyopathy	0.00111	0.00264	CcSEcCtD
Cyclophosphamide—Flushing—Lisinopril—dilated cardiomyopathy	0.00111	0.00263	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00111	0.00263	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.0011	0.0026	CcSEcCtD
Cyclophosphamide—Anorexia—Furosemide—dilated cardiomyopathy	0.00108	0.00256	CcSEcCtD
Cyclophosphamide—Chills—Lisinopril—dilated cardiomyopathy	0.00107	0.00254	CcSEcCtD
Cyclophosphamide—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00107	0.00253	CcSEcCtD
Cyclophosphamide—Hypotension—Furosemide—dilated cardiomyopathy	0.00106	0.00251	CcSEcCtD
Cyclophosphamide—Alopecia—Lisinopril—dilated cardiomyopathy	0.00106	0.00251	CcSEcCtD
Cyclophosphamide—Erythema—Lisinopril—dilated cardiomyopathy	0.00104	0.00247	CcSEcCtD
Cyclophosphamide—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00102	0.00242	CcSEcCtD
Cyclophosphamide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00102	0.00241	CcSEcCtD
Cyclophosphamide—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.001	0.00237	CcSEcCtD
Cyclophosphamide—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000985	0.00233	CcSEcCtD
Cyclophosphamide—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000982	0.00233	CcSEcCtD
Cyclophosphamide—Fatigue—Furosemide—dilated cardiomyopathy	0.000977	0.00231	CcSEcCtD
Cyclophosphamide—Tremor—Lisinopril—dilated cardiomyopathy	0.000976	0.00231	CcSEcCtD
Cyclophosphamide—Constipation—Furosemide—dilated cardiomyopathy	0.000969	0.0023	CcSEcCtD
Cyclophosphamide—Pain—Furosemide—dilated cardiomyopathy	0.000969	0.0023	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000966	0.00229	CcSEcCtD
Cyclophosphamide—Anaemia—Lisinopril—dilated cardiomyopathy	0.000963	0.00228	CcSEcCtD
Cyclophosphamide—Malaise—Lisinopril—dilated cardiomyopathy	0.000939	0.00223	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000934	0.00221	CcSEcCtD
Cyclophosphamide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000932	0.00221	CcSEcCtD
Cyclophosphamide—Palpitations—Lisinopril—dilated cardiomyopathy	0.00092	0.00218	CcSEcCtD
Cyclophosphamide—Cough—Lisinopril—dilated cardiomyopathy	0.000909	0.00215	CcSEcCtD
Cyclophosphamide—Urticaria—Furosemide—dilated cardiomyopathy	0.0009	0.00213	CcSEcCtD
Cyclophosphamide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000896	0.00212	CcSEcCtD
Cyclophosphamide—Chest pain—Lisinopril—dilated cardiomyopathy	0.000887	0.0021	CcSEcCtD
Cyclophosphamide—Myalgia—Lisinopril—dilated cardiomyopathy	0.000887	0.0021	CcSEcCtD
Cyclophosphamide—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000887	0.0021	CcSEcCtD
Cyclophosphamide—Discomfort—Lisinopril—dilated cardiomyopathy	0.000876	0.00208	CcSEcCtD
Cyclophosphamide—Confusional state—Lisinopril—dilated cardiomyopathy	0.000857	0.00203	CcSEcCtD
Cyclophosphamide—Oedema—Lisinopril—dilated cardiomyopathy	0.00085	0.00201	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00085	0.00201	CcSEcCtD
Cyclophosphamide—Infection—Lisinopril—dilated cardiomyopathy	0.000844	0.002	CcSEcCtD
Cyclophosphamide—Shock—Lisinopril—dilated cardiomyopathy	0.000836	0.00198	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000835	0.00198	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000832	0.00197	CcSEcCtD
Cyclophosphamide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00083	0.00197	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000822	0.00195	CcSEcCtD
Cyclophosphamide—Asthenia—Furosemide—dilated cardiomyopathy	0.000813	0.00193	CcSEcCtD
Cyclophosphamide—Anorexia—Lisinopril—dilated cardiomyopathy	0.00081	0.00192	CcSEcCtD
Cyclophosphamide—Pruritus—Furosemide—dilated cardiomyopathy	0.000801	0.0019	CcSEcCtD
Cyclophosphamide—Hypotension—Lisinopril—dilated cardiomyopathy	0.000794	0.00188	CcSEcCtD
Cyclophosphamide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000775	0.00184	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000774	0.00184	CcSEcCtD
Cyclophosphamide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000763	0.00181	CcSEcCtD
Cyclophosphamide—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000758	0.0018	CcSEcCtD
Cyclophosphamide—Dizziness—Furosemide—dilated cardiomyopathy	0.000749	0.00178	CcSEcCtD
Cyclophosphamide—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000739	0.00175	CcSEcCtD
Cyclophosphamide—Fatigue—Lisinopril—dilated cardiomyopathy	0.000733	0.00174	CcSEcCtD
Cyclophosphamide—Pain—Lisinopril—dilated cardiomyopathy	0.000727	0.00172	CcSEcCtD
Cyclophosphamide—Constipation—Lisinopril—dilated cardiomyopathy	0.000727	0.00172	CcSEcCtD
Cyclophosphamide—Vomiting—Furosemide—dilated cardiomyopathy	0.00072	0.00171	CcSEcCtD
Cyclophosphamide—Rash—Furosemide—dilated cardiomyopathy	0.000714	0.00169	CcSEcCtD
Cyclophosphamide—Dermatitis—Furosemide—dilated cardiomyopathy	0.000714	0.00169	CcSEcCtD
Cyclophosphamide—Headache—Furosemide—dilated cardiomyopathy	0.00071	0.00168	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0007	0.00166	CcSEcCtD
Cyclophosphamide—Urticaria—Lisinopril—dilated cardiomyopathy	0.000675	0.0016	CcSEcCtD
Cyclophosphamide—Nausea—Furosemide—dilated cardiomyopathy	0.000673	0.00159	CcSEcCtD
Cyclophosphamide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000672	0.00159	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000626	0.00148	CcSEcCtD
Cyclophosphamide—Asthenia—Lisinopril—dilated cardiomyopathy	0.00061	0.00145	CcSEcCtD
Cyclophosphamide—Pruritus—Lisinopril—dilated cardiomyopathy	0.000601	0.00143	CcSEcCtD
Cyclophosphamide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000582	0.00138	CcSEcCtD
Cyclophosphamide—Dizziness—Lisinopril—dilated cardiomyopathy	0.000562	0.00133	CcSEcCtD
Cyclophosphamide—Vomiting—Lisinopril—dilated cardiomyopathy	0.00054	0.00128	CcSEcCtD
Cyclophosphamide—Rash—Lisinopril—dilated cardiomyopathy	0.000536	0.00127	CcSEcCtD
Cyclophosphamide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000535	0.00127	CcSEcCtD
Cyclophosphamide—Headache—Lisinopril—dilated cardiomyopathy	0.000532	0.00126	CcSEcCtD
Cyclophosphamide—Nausea—Lisinopril—dilated cardiomyopathy	0.000505	0.0012	CcSEcCtD
